Silver and Antibiotic, New Facts to an Old Story
AbstractThe therapeutic arsenal against bacterial infections is rapidly shrinking, as drug resistance spreads and pharmaceutical industry are struggling to produce new antibiotics. In this review we cover the efficacy of silver as an antibacterial agent. In particular we recall experimental evidences pointing to the multiple targets of silver, including DNA, proteins and small molecules, and we review the arguments for and against the hypothesis that silver acts by enhancing oxidative stress. We also review the recent use of silver as an adjuvant for antibiotics. Specifically, we discuss the state of our current understanding on the potentiating action of silver ions on aminoglycoside antibiotics. View Full-Text
Share & Cite This Article
Barras, F.; Aussel, L.; Ezraty, B. Silver and Antibiotic, New Facts to an Old Story. Antibiotics 2018, 7, 79.
Barras F, Aussel L, Ezraty B. Silver and Antibiotic, New Facts to an Old Story. Antibiotics. 2018; 7(3):79.Chicago/Turabian Style
Barras, Frédéric; Aussel, Laurent; Ezraty, Benjamin. 2018. "Silver and Antibiotic, New Facts to an Old Story." Antibiotics 7, no. 3: 79.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.